Rabies vaccine recombinant (Sanofi Pasteur)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRabies vaccine recombinant (Sanofi Pasteur)
Drug Alias NameRabies vaccine glycoprotein - Aventis PasteurvCP 65ALVAC RG
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsRabies

Other Information

ATC CodeN/A
Related LinksN/A